Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses
Publication date: August 2026 Source: Journal of the National Cancer Center, Volume 6, Issue 4 Author(s): Zhicheng Lai, Zefeng Du, Lichang Huang, Qijiong Li, Yexing Huang, Li Xu, Wei Wei, Yaojun Zhang, Minshan Chen, Ming Shi, Anna Kan, Minke He
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses. // Journal of the National Cancer Center. – URL: https://www.sciencedirect.com/science/article/pii/S266700542600058X?dgcid=rss_sd_all
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses. Journal of the National Cancer Center. https://www.sciencedirect.com/science/article/pii/S266700542600058X?dgcid=rss_sd_all
“Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses.” Journal of the National Cancer Center.
@article{article55771,
title = {Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses},
journal = {Journal of the National Cancer Center},
url = {https://www.sciencedirect.com/science/article/pii/S266700542600058X?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment